Valo Health has raised about $100 million in its Series A round, $50 million in undisclosed financing, and $190 million in its Series B round. While it is far from a clinic, Valo has drawn new investors from Koch Disruptive Technology, an arm of the Koch Industries. Although the firm has not ventured into biotech yet, it sees the possibility of disrupting the way drugs are thought about.
Valo Health uses “omics” data to identify associations between genetic markers and disease
A multi-omics approach involves the use of high-throughput technologies to analyze a large number of different molecules. Such a process can help scientists understand the flow of information in a disease’s genome, paving the way for new discoveries in the treatment of the disease. Traditional single-omics technologies, such as DNA sequencing, can only provide correlations, reflecting reactive processes. In contrast, multi-omics approaches can explain changes that are causative, identifying therapeutic targets.
Digital engagement tools help patients self-monitor and stay motivated
A patient’s care journey is more convenient with the use of digital engagement tools. Today, 90% of patients want technology-driven care and 66% don’t mind using apps to achieve their preferred health outcomes. Digital patient engagement tools are effective in managing health and are highly customizable. They can improve the overall patient experience by facilitating communication with providers and providing a convenient way for patients to self-monitor their health.
With the use of digital engagement tools, patients can monitor and maintain their health, stay motivated and minimize medical errors. These digital tools can also streamline administrative processes, reducing no-show appointments, and rescheduling. These tools also improve patient activation levels by giving patients a voice in their health records, connect with others, and communicate with their providers. To ensure privacy and security, healthcare organizations must integrate digital engagement tools into their workflow.
Patient data can provide an improved understanding of the patient’s health and can be used to identify hesitancy and resistance to care. Automated PGHD entry can streamline workflow and improve functionality. In addition to patient data collection, automated PGHD entry can reduce healthcare costs. Further, patient engagement tools are helpful for clinicians and patients alike. These tools can help improve the patient experience while reducing medical costs.
Artificial intelligence helps patients stay motivated
In a recent study, researchers at alo Health demonstrated how artificial intelligence can improve EM protocols by assessing patients’ achievement and adherence to their schedules. Such systems could also help them manage the emotional side effects of PICS treatments. Researchers hope to apply these ideas to other healthcare settings. In the meantime, the technology can help patients stay motivated and improve treatment compliance. But, how can these innovations benefit patients and caregivers read more?